Research ExplorerPublicationsHomografts and extra-anatomical reconstructions for infected...

Homografts and extra-anatomical reconstructions for infected vascular grafts

Standard

Homografts and extra-anatomical reconstructions for infected vascular grafts. / Diener, H; Hellwinkel, Olaf; Carpenter, S; Larena-Avellaneda, A; Debus, E S.

In: J CARDIOVASC SURG, Vol. 55, No. 2 Suppl 1, 01.04.2014, p. 217-23.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Diener, H, Hellwinkel, O, Carpenter, S, Larena-Avellaneda, A & Debus, ES 2014, 'Homografts and extra-anatomical reconstructions for infected vascular grafts', J CARDIOVASC SURG, vol. 55, no. 2 Suppl 1, pp. 217-23.

APA

Diener, H., Hellwinkel, O., Carpenter, S., Larena-Avellaneda, A., & Debus, E. S. (2014). Homografts and extra-anatomical reconstructions for infected vascular grafts. J CARDIOVASC SURG, 55(2 Suppl 1), 217-23.

Vancouver

Diener H, Hellwinkel O, Carpenter S, Larena-Avellaneda A, Debus ES. Homografts and extra-anatomical reconstructions for infected vascular grafts. J CARDIOVASC SURG. 2014 Apr 1;55(2 Suppl 1):217-23.

Bibtex

@article{ce2a866aa11442518237047cb1f73d3e,
title = "Homografts and extra-anatomical reconstructions for infected vascular grafts",
abstract = "Managing graft infections is a challenge in vascular surgery. The incidence of vascular graft infections varies between 2% and 6%. The number of patients treated by means of implantation of artificial prostheses is constantly growing. The treatment of vascular graft infections remains controversial. This article discusses in-situ repair and the role of extra-anatomic routes. Homografts present the lowest rate of reinfection with acceptable rates of degradation and aneurysm formation. Silvergrafts and synthetic grafts coated with antimicrobials show similar early and late mortality rates, but higher reinfection rates. The outcome extra-anatomic bypass surgery seems to be improved in actual series compared with historical results but their disadvantages (limited patency, higher rate of amputations as well as high rates of reintervention combined with higher early mortality) are obvious.",
keywords = "Allografts, Amputation, Anti-Bacterial Agents, Bioprosthesis, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation, Coated Materials, Biocompatible, Device Removal, Humans, Limb Salvage, Prosthesis Design, Prosthesis-Related Infections, Reconstructive Surgical Procedures, Recurrence, Reoperation, Risk Factors, Treatment Outcome",
author = "H Diener and Olaf Hellwinkel and S Carpenter and A Larena-Avellaneda and Debus, {E S}",
year = "2014",
month = apr,
day = "1",
language = "English",
volume = "55",
pages = "217--23",
journal = "J CARDIOVASC SURG",
issn = "0021-9509",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2 Suppl 1",

}

RIS

TY - JOUR

T1 - Homografts and extra-anatomical reconstructions for infected vascular grafts

AU - Diener, H

AU - Hellwinkel, Olaf

AU - Carpenter, S

AU - Larena-Avellaneda, A

AU - Debus, E S

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Managing graft infections is a challenge in vascular surgery. The incidence of vascular graft infections varies between 2% and 6%. The number of patients treated by means of implantation of artificial prostheses is constantly growing. The treatment of vascular graft infections remains controversial. This article discusses in-situ repair and the role of extra-anatomic routes. Homografts present the lowest rate of reinfection with acceptable rates of degradation and aneurysm formation. Silvergrafts and synthetic grafts coated with antimicrobials show similar early and late mortality rates, but higher reinfection rates. The outcome extra-anatomic bypass surgery seems to be improved in actual series compared with historical results but their disadvantages (limited patency, higher rate of amputations as well as high rates of reintervention combined with higher early mortality) are obvious.

AB - Managing graft infections is a challenge in vascular surgery. The incidence of vascular graft infections varies between 2% and 6%. The number of patients treated by means of implantation of artificial prostheses is constantly growing. The treatment of vascular graft infections remains controversial. This article discusses in-situ repair and the role of extra-anatomic routes. Homografts present the lowest rate of reinfection with acceptable rates of degradation and aneurysm formation. Silvergrafts and synthetic grafts coated with antimicrobials show similar early and late mortality rates, but higher reinfection rates. The outcome extra-anatomic bypass surgery seems to be improved in actual series compared with historical results but their disadvantages (limited patency, higher rate of amputations as well as high rates of reintervention combined with higher early mortality) are obvious.

KW - Allografts

KW - Amputation

KW - Anti-Bacterial Agents

KW - Bioprosthesis

KW - Blood Vessel Prosthesis

KW - Blood Vessel Prosthesis Implantation

KW - Coated Materials, Biocompatible

KW - Device Removal

KW - Humans

KW - Limb Salvage

KW - Prosthesis Design

KW - Prosthesis-Related Infections

KW - Reconstructive Surgical Procedures

KW - Recurrence

KW - Reoperation

KW - Risk Factors

KW - Treatment Outcome

M3 - SCORING: Journal article

C2 - 24796916

VL - 55

SP - 217

EP - 223

JO - J CARDIOVASC SURG

JF - J CARDIOVASC SURG

SN - 0021-9509

IS - 2 Suppl 1

ER -